It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
2d
MedPage Today on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
14h
ZME Science on MSNOzempic Users Are Drinking Less Alcohol Without Even TryingIn a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...
“These drugs may sort of turn down the gain on the reward system in the brain ... to effectively reduce alcohol consumption among six people with addiction. (The drug Stainbrook is taking ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
GLP-1 medications that have helped people lose weight may also help people drink less alcohol, according to new ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results